For the latest COVID-19 campus news and resources, visit

Search Close Search
Page Menu



The Donahue lab, along with collaborators, invented cardiac arrhythmia gene therapy. We created clinically relevant, preclinical test models of atrial fibrillation and post-infarction ventricular tachycardia.  With these models, we have identified novel disease mechanisms and developed arrhythmia gene therapies that are making their way through preclinical and starting clinical testing.